Arisha Patel

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study

Milind Javle, Mitesh J. Borad, Nilofer S. Azad et al. · The Lancet Oncology · 2021 · 383 citations

Medicine, Biliary Cancer, Pathology +6

Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study

Claire F. Friedman, John D. Hainsworth, Razelle Kurzrock et al. · Cancer Discovery · 2021 · 95 citations · Full text

The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T‐cell lymphoma, nasal type, in the United States

John A. Vargo, Arisha Patel, Scott Glaser et al. · Cancer · 2017 · 70 citations · Full text

MyPathway HER2 basket study: Pertuzumab (P) + trastuzumab (H) treatment of a large, tissue-agnostic cohort of patients with HER2-positive advanced solid tumors.

Funda Meric‐Bernstam, John D. Hainsworth, Ron Bose et al. · Journal of Clinical Oncology · 2021 · 47 citations

Breast Oncology, Solid Tumors, Medicine +15

Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission

Arisha Patel, Mounzer Agha, Anastasios Raptis et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2020 · 13 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +14